The p53 sensor was combined with diphtheria toxin (DT) using the CRISPR-Cas9 system to specifically kill p53-deficient tumour cells by getting activated in presence of WT p53, therefore protecting normal cells from DT. The gene discussed is TP53; the disease is neoplasm.